Global Pharmaceuticals & Biotech Breakout Stocks

Twist Bioscience

Market Cap: US$6.2b

Manufactures and sells synthetic DNA-based products.

CareDx

Market Cap: US$2.4b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Pell Bio-Med Technology

Market Cap: NT$63.3b

A biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products.

Neuren Pharmaceuticals

Market Cap: AU$2.7b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Obsidian Therapeutics

Market Cap: US$1.8b

Operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.

Alivus Life Sciences

Market Cap: ₹162.7b

Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.

Lin BioScience

Market Cap: NT$52.8b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

Sino BiologicalInc

Market Cap: CN¥10.9b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

Shilpa Medicare

Market Cap: ₹144.7b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

PYC Therapeutics

Market Cap: AU$2.1b

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Replimune Group

Market Cap: US$993.3m

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom.

Zhejiang Wecome Pharmaceutical

Market Cap: CN¥4.8b

Engages in the research and development, production, and sale of modern Chinese and western medicine in China.

Cybin

Market Cap: US$575.2m

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.

GlaxoSmithKlineE

Market Cap: ج.م27.7b

Engages in production of pharmaceutical chemicals.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥3.7b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Morepen Laboratories

Market Cap: ₹43.6b

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

Egyptian International Pharmaceutical Industries

Market Cap: ج.م21.9b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م13.6b

Develops, produces, and sells pharmaceutical products in Egypt.

Fredun Pharmaceuticals

Market Cap: ₹20.2b

Manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America.

Japan Tissue Engineering

Market Cap: JP¥32.4b

Engages in the regenerative medicine business in Japan.

Pyxis Oncology

Market Cap: US$198.3m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

PepGen

Market Cap: US$137.0m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

Tien Liang BioTech

Market Cap: NT$3.9b

Manufactures and sells pharmaceutical products in Taiwan.

Nyrada

Market Cap: AU$167.9m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

Yarrow Bioscience

Market Cap: US$105.6m

Operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.

Ahn-Gook Pharmaceutical

Market Cap: ₩142.7b

Manufactures and sells pharmaceutical products.

JW Shinyak

Market Cap: ₩130.2b

Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.

Poolbeg Pharma

Market Cap: UK£63.4m

A clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom.

Eloxx Pharmaceuticals

Market Cap: US$71.8m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia.

IMGTLtd

Market Cap: ₩70.9b

Engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.

BetterLife Pharma

Market Cap: US$40.5m

A biotechnology company, engages in the development of psychedelic-derived compounds.

Ambalal Sarabhai Enterprises

Market Cap: ₹3.4b

Manufactures, markets, and supplies pharmaceutical products in India and internationally.

EOM Pharmaceuticals Holdings

Market Cap: US$27.8m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

Vectus Biosystems

Market Cap: AU$9.8m

Engages in the medical research and development activities in Australia.

Green Zebras Spolka Akcyjna

Market Cap: zł17.1m

Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.

American Green

Market Cap: US$1.3m

Operates as a technology company in the medical cannabis industry in the United States.